These numbers are well in the range of established screening tests, e.g. for prostate cancer by prostate specific antigen (PSA) (positive predictive value = 25.1%, sensitivity = 72.1%, specificity = 93.2%, [37]), albeit with a higher predictive value at the cost of reduced sensitivity. Here, KLK3 is linked to prostate carcinoma.